Filing Details

Accession Number:
0001209191-18-041916
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-06 20:04:11
Reporting Period:
2018-07-03
Accepted Time:
2018-07-06 20:04:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
921299 Fibrogen Inc FGEN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1420987 A James Schoeneck C/O Fibrogen, Inc.
409 Illinois St.
San Francisco CA 94158
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-07-03 7,639 $2.90 11,339 No 4 M Direct
Common Stock Disposition 2018-07-03 7,639 $65.00 3,700 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-07-03 7,639 $0.00 7,639 $2.90
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,000 2020-04-27 No 4 M Direct
Footnotes
  1. Shares sold pursuant to a 10b5-1 plan.
  2. Fully vested.